MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Gross Profit Summary of MedPacto, Inc.

MedPacto, Inc.'s latest annual gross profit in 2023 was -1.83 Billion KRW , up 1.8% from previous year.
MedPacto, Inc.'s latest quarterly gross profit in 2024 Q2 was -391.19 Million KRW , up 6.62% from previous quarter.
MedPacto, Inc. reported a annual gross profit of -1.86 Billion KRW in annual gross profit 2022, down -8.29% from previous year.
MedPacto, Inc. reported a annual gross profit of -1.72 Billion KRW in annual gross profit 2021, down -19.91% from previous year.
MedPacto, Inc. reported a quarterly gross profit of -418.9 Million KRW for 2024 Q1, up 0.65% from previous quarter.
MedPacto, Inc. reported a quarterly gross profit of -421.64 Million KRW for 2023 Q4, up 8.92% from previous quarter.

Annual Gross Profit Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Gross Profit of MedPacto, Inc. (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	-1.83 Billion KRW	1.8%
2022	-1.86 Billion KRW	-8.29%
2021	-1.72 Billion KRW	-19.91%
2020	-1.43 Billion KRW	-72.01%
2019	-835.57 Million KRW	-339.17%
2018	-190.26 Million KRW	-11.86%
2017	-170.08 Million KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	-391.19 Million KRW	6.62%
2024 Q1	-418.9 Million KRW	0.65%
2023 Q4	-421.64 Million KRW	8.92%
2023 FY	-1.83 Billion KRW	1.8%
2023 Q3	-462.94 Million KRW	2.3%
2023 Q2	-473.84 Million KRW	0.08%
2023 Q1	-474.23 Million KRW	8.87%
2022 Q2	-427.57 Million KRW	7.49%
2022 FY	-1.86 Billion KRW	-8.29%
2022 Q3	-456.12 Million KRW	-6.68%
2022 Q4	-520.36 Million KRW	-14.08%
2022 Q1	-462.18 Million KRW	-2.84%
2021 Q1	-411.87 Million KRW	0.0%
2021 Q3	-435.22 Million KRW	-1.97%
2021 Q2	-426.82 Million KRW	-3.63%
2021 Q4	-449.44 Million KRW	-3.27%
2021 FY	-1.72 Billion KRW	-19.91%
2020 Q3	- KRW	0.0%
2020 FY	-1.43 Billion KRW	-72.01%
2020 Q4	- KRW	0.0%
2019 FY	-835.57 Million KRW	-339.17%
2018 FY	-190.26 Million KRW	-11.86%
2017 FY	-170.08 Million KRW	0.0%

Peer Gross Profit Comparison of MedPacto, Inc.

Name	Gross Profit	Gross Profit Difference
HLB Co., Ltd.	-6.01 Billion KRW	69.519%
iNtRON Biotechnology, Inc.	4.56 Billion KRW	140.182%
BINEX Co., Ltd.	56.65 Billion KRW	103.235%
Bioneer Corporation	199.25 Billion KRW	100.92%
Anterogen.Co.,Ltd.	2.21 Billion KRW	182.797%
MEDIPOST Co., Ltd.	40.18 Billion KRW	104.561%
CrystalGenomics, Inc.	1.45 Billion KRW	225.783%
Helixmith Co., Ltd	2.12 Billion KRW	186.371%
Chabiotech Co.,Ltd.	255.19 Billion KRW	100.718%
Medy-Tox Inc.	128.16 Billion KRW	101.43%
Peptron, Inc.	1.14 Billion KRW	260.678%
Amicogen, Inc.	51.51 Billion KRW	103.558%
Genexine, Inc.	387.48 Million KRW	572.964%
HLB Therapeutics Co.,Ltd.	6.69 Billion KRW	127.377%
LegoChem Biosciences, Inc.	17.79 Billion KRW	110.297%
ALTEOGEN Inc.	31.19 Billion KRW	105.874%
PharmaResearch Co., Ltd.	182.25 Billion KRW	101.006%
SillaJen, Inc.	1.45 Billion KRW	225.806%
JETEMA, Co., Ltd.	26.58 Billion KRW	106.894%
OliX Pharmaceuticals,Inc	14.42 Billion KRW	112.707%
Genomictree Inc.	-1.03 Billion KRW	-76.456%
D&D Pharmatech	18.67 Billion KRW	109.812%
EASY BIO,Inc.	50.88 Billion KRW	103.602%
GI Innovation, Inc.	1.98 Billion KRW	192.12%